CHAMPIONS ONCOLOGY, INC.
CSBRNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CSBR. That does not mean none is planned.
Get an email about CSBR's next catalysts
Track CHAMPIONS ONCOLOGY (CSBR) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
CSBR Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Oct/2026 | Call: tbd
Market Overview
Stock performance and key metrics
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist.
No drugs found in this phase.
Frequently asked questions
When is CHAMPIONS ONCOLOGY, INC.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for CHAMPIONS ONCOLOGY, INC. (CSBR) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track CSBR biotech catalysts?β
Add CSBR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow CHAMPIONS ONCOLOGY, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
